ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy.

ASTRO Responds to Troubling Medicare Cuts, Radiation Oncology Model Update

July 20, 2021 — In response to consecutive weeks of proposed Medicare payment cuts to radiation oncology cancer care,...
ASTRO 2021 Announces its October Event is In-person

July 8, 2021 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 63rd Annual Meeting, which will return to an in-person conference at ...
Talking Trends with Elekta

Treating cancer effectively often includes a combination of patient therapies.
Mary C. Mahoney, MD, Named RSNA President

December 1, 2020 — At the Virtual RSNA 2020 conference, it was announced that Mary C. Mahoney, M.D., is RSNA president for 2021.
Radiation Oncologists Urge Congress to Advance Bills That Protect Patient Access to Cancer Care During Pandemic

November 18, 2020 — Radiation oncologists across the country will meet virtually with members of Congress this week to urge lawmakers to pass legislation that will safeguard access to high-quality, value-based health care for...

the Centers for Medicare & Medicaid Services (CMS) displayed the CY 2022 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems (OPPS/ASC) Notice of Proposed Rulemaking (CMS-1753-P), which includes proposals related to the Radiation Oncology (RO) Model.

Getty Images

News | Radiation Oncology | July 21, 2021

Notice of Proposed Rulemaking for the Radiation Oncology (RO) Model

July 21, 2021 — On July 19, 2021, the Centers for Medicare & Medicaid Services (CMS) displayed the CY 2022 Hospital...

ASTRO just issued the following statement in response to the Radiation Oncology Model update in yesterday's HOPPS proposed rule, which compounds significant and detrimental cuts to the cancer care specialty in the proposed 2022 MPFS

Getty Images

News | Radiation Therapy | July 20, 2021

ASTRO Responds to Troubling Medicare Cuts, Radiation Oncology Model Update

July 20, 2021 — In response to consecutive weeks of proposed Medicare payment cuts to radiation oncology cancer care,...

American Society for Radiation Oncology (ASTRO) to host in-person Annual Meeting in Chicago, October 24-27

Getty Images

News | ASTRO | July 08, 2021

ASTRO 2021 Announces its October Event is In-person

July 8, 2021 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 63rd Annual Meeting,...

Sponsored Content

Blog | Artificial Intelligence | June 07, 2021

BLOG: Auto-Segmentation in Radiation Oncology: Things to Consider

Automation is transforming the way we practice radiation oncology and advancing the standard of patient care. There...

The pandemic threw everyone a curve ball that most didn’t see coming, at least at the magnitude that it hit. The year brought about a lot of change — which built some new models for business operation, and opened up avenues of discussion for others.

Getty Images

Blog | Coronavirus (COVID-19) | July 02, 2021

Watching 2021 Unfold

Slowly, we are seeing our world come back into focus. The pandemic threw everyone a curve ball that most didn’t see...

$The two-year project focused on reducing the use of extended-fraction radiation therapy to treat pain from incurable cancer that had spread to patients’ bones. Once a standard practice, the American Society for Radiation Oncology (ASTRO) has recommended against the routine use of extended-fraction radiation to relieve pain from bone metastases, especially more than 10 treatments.$

Multiple cancer metastasis to the pelvic bone and femur bones. Getty Images

News | Radiation Therapy | June 24, 2021

Statewide Quality Improvement Project Reduced Excessive Radiation Treatments for Bone Metastases by 80%

June 24, 2021 — An effort by the Michigan Radiation Oncology Quality Consortium reduced excessive radiation treatments...

Mevion Medical Systems announced that the first proton center in the Mountain West, the Senator Orrin G. Hatch Center for Proton Therapy, has opened at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) and began treating patients on May 11 with the MEVION S250i Proton Therapy System.

The teams from HCI, U of U and Mevion gather to celebrate the center’s grand opening. Group from left to right: Bill Salter, Ph.D., Senior Director of Radiation Oncology, HCI and Professor and Chief of the Division of Medical Physics, U of U -- Robyn Walker, Sr. Director, Customer Success and Service Operations, Mevion -- James Cooley, Ph.D., Director of Advanced Development, Mevion -- Dennis Shrieve, M.D., Ph.D., Chair in Cancer Research, HCI and Chair of Department of Radiation Oncology, U of U -- Tina Yu, Ph.D., CEO, Mevion -- Michael Good, M.D., Interim President, U of U and Sr. VP for Health Sciences, U of U Health -- Ying Hitchcock, M.D., Professor and Medical Director, Department of Radiation Oncology, U of U. (Photo: Business Wire)

News | Proton Therapy | June 24, 2021

Huntsman Cancer Institute Begins Treatment with Mevion Compact Proton Therapy System

June 24, 2021 — Mevion Medical Systems announced that the first proton center in the Mountain West, the Senator Orrin G...

Sponsored Content

Videos | Information Technology | December 01, 2020

Talking Trends with Elekta

Treating cancer effectively often includes a combination of patient therapies. In recent years, technology advancements...

Sponsored Content | Blog | Artificial Intelligence | June 07, 2021

BLOG: Auto-Segmentation in Radiation Oncology: Things to Consider

Automation is transforming the way we practice radiation oncology and advancing the standard of patient care. There...

Winship Cancer Institute of Emory University’s EMPIRE-1 trial is first-of-its-kind randomized patient outcomes study of amino acid PET imaging in influencing a cancer control endpoint

News | Radiation Therapy | May 25, 2021

Results Published for Axumin (Fluciclovine F 18) PET Imaging Study Demonstrating Improved Patient Outcomes in Patients with Recurrent Prostate Cancer

May 25, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization...

Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

News | Artificial Intelligence | April 07, 2021

Vysioneer Receives FDA Clearance on First-Ever Tumor Auto-Contouring Solution for Radiation Therapy

April 7, 2021 — Vysioneer, a leader in artificial intelligence (AI) for cancer care, announced it received the U.S....

The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.

News | Radiation Therapy | March 31, 2021

ASTRO Survey Finds Pandemic Has Led to More Advanced-stage Cancer Diagnoses

March 31, 2021 — Doctors who oversee cancer clinics say that new patients are arriving for treatment with more advanced...

Diagnostic imaging studies using Tc-99m inform healthcare decisions for approximately 30 million patients annually around the world

News | Nuclear Imaging | March 08, 2021

IBA and NorthStar Medical Radioisotopes Expand Collaboration to Enable Global Availability of Tc-99m

March 8, 2021 — IBA (Ion Beam Applications S.A., EURONEXT) and NorthStar Medical Radioisotopes, LLC, announced a...

Axial fused PET/CT image shows intense uptake (arrowhead) in the deep pelvis corresponding to the left lobe of the prostate in a 62-year-old with a history of prostate cancer treated with radiation therapy. The CT scan does not show the tumor. Image courtesy of the the Radiological Society of North America.

Axial fused PET/CT image shows intense uptake (arrowhead) in the deep pelvis corresponding to the left lobe of the prostate in a 62-year-old with a history of prostate cancer treated with radiation therapy. The CT scan does not show the tumor. Image courtesy of the the Radiological Society of North America.

Feature | Treatment Planning | March 05, 2021 | By Melinda Taschetta-Millane

Using PET to Enhance Prostate Treatment Planning

The decision to offer radiation after prostatectomy for patients with recurrent prostate cancer is quite complex, and...

ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized ZAP-X Gyroscopic Radiosurgery platform.

News | Stereotactic Body Radiation Therapy (SBRT) | February 12, 2021

ZAP Surgical Builds Market for its Novel ZAP-X Gyroscopic Radiosurgery Platform

February 12, 2021 — ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized...

Sponsored Content | Sponsored Content | Videos | Information Technology | December 01, 2020

Talking Trends with Elekta

Treating cancer effectively often includes a combination of patient therapies. In recent years, technology advancements...

Mary C. Mahoney, M.D.

News | RSNA | December 01, 2020

Mary C. Mahoney, MD, Named RSNA President

December 1, 2020 — At the Virtual RSNA 2020 conference, it was announced that Mary C. Mahoney, M.D., is RSNA president...

Radiation oncologists across the country will meet virtually with members of Congress this week to discuss value-based payment, prior authorization and supporting cancer care during the pandemic

Getty Images

News | Radiation Oncology | November 18, 2020

Radiation Oncologists Urge Congress to Advance Bills That Protect Patient Access to Cancer Care During Pandemic

November 18, 2020 — Radiation oncologists across the country will meet virtually with members of Congress this week to...

Metastasis-free survival is a strong surrogate endpoint for overall survival over biochemical failure for men receiving salvage radiotherapy for recurrent prostate cancer

Getty Images

News | Prostate Cancer | November 02, 2020

MFS Is a Strong Surrogate Endpoint for OS for Men Receiving Salvage RT

November 2, 2020 — An analysis of the phase III NRG Oncology clinical trial RTOG 9601 on men receiving salvage...

Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer. Image courtesy of the American College of Surgeons

Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer. Image courtesy of the American College of Surgeons

News | Radiation Therapy | November 02, 2020

Some Rectal Cancer Patients Can Safely Avoid an Aggressive Operation

November 2, 2020 — A nonsurgical treatment option for rectal cancer that preserves quality of life is safe for...